Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-05-18
1994-07-05
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 43, 435 85, 435 87, 536 271, C07D27300, A61K 3100
Patent
active
053267540
ABSTRACT:
An antitumor antibiotic designated BMY-41219 is produced by fermentation of Saccharothrix aerocolonigenes ATCC 39243. The BMY-41219 antibiotic exhibits antitumor activity.
REFERENCES:
patent: 4487925 (1984-12-01), Nettleton, Jr. et al.
patent: 4524145 (1985-06-01), Matson et al.
patent: 4552842 (1985-11-01), Nettleton, Jr. et al.
patent: 4567143 (1986-01-01), Matson et al.
patent: 4785085 (1988-11-01), Kaneko et al.
patent: 4808613 (1989-02-01), Kaneko et al.
patent: 5158938 (1992-10-01), Lam et al.
Forenza Salvatore
Lam Kin S.
Matson James A.
Mattei Jacqueline
McDonald Leonard A.
Bristol-Myers Squibb Co.
Griffin Ronald W.
Nolan Sandra M.
Wilson James O.
LandOfFree
Antitumor antibiotic BMY-41219 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumor antibiotic BMY-41219, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor antibiotic BMY-41219 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-796041